头颈部微血管游离组织移植术后预防性抗生素结束后重启治疗性抗生素的相关因素
回顾性分析2015年1月至2020年7月连续501例头颈部微血管游离组织移植(HN-MFTT)病例,42%在术后30天内重启抗生素,最常见指征为皮瓣受区感染、医院获得性肺炎和伤口裂开/波动感/引流液性质改变。较短预防用药(≤24小时)、骨皮瓣、既往免疫/化疗与手术感染重启抗生素相关;气道消化道缺损、心血管病、ASA 3-4级与院内感染重启抗生素相关。
要点
- HN-MFTT术后30天内42%患者重启治疗性抗生素,手术感染与院内感染风险因素不同。
- 预防用药≤24小时、骨皮瓣、既往化疗/免疫治疗与手术感染重启抗生素相关。
- 气道消化道缺损、心血管病、ASA 3-4级与院内感染重启抗生素相关。
核心结论
- 气道消化道重建、术后24小时预防性抗生素、美国麻醉医师协会(ASA)3级和4级、既往化疗/免疫治疗、心血管疾病和骨皮瓣与HN-MFTT术后30天内重启抗生素相关。
研究设计与样本
- 回顾性研究,纳入2015年1月至2020年7月连续进行的HN-MFTT,共482例患者、501次手术,按预防用药时长分层:≤24小时(n=136,27.1%)、25-72小时(n=54,10.8%)、>72小时(n=311,62.1%)。
主要发现
- 199例患者(209次手术,42%)重启抗生素;最常见指征为皮瓣受区感染(n=59,28%)、医院获得性肺炎(n=44,21%)、伤口裂开/波动感/引流液性质改变(n=44,21%)。
- 手术感染重启抗生素与较短预防用药(≤24小时)(OR 1.95;95%CI 1.2-3.0;P=.003)、骨皮瓣(OR 2.15;95%CI 1.3-3.4;P=.001)、既往免疫/化疗(OR 2.29;95%CI 1.2-4.3;P=.01)相关。
- 院内感染重启抗生素与气道消化道缺损(OR 2.45;95%CI 1.1-5.2;P=.019)、心血管疾病(OR 3.00;95%CI 1.5-5.9;P=.001)、ASA 3或4级(OR 2.83;95%CI 1.5-5.4;P=.002)相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine factors associated with restarting therapeutic antibiotics within 30 days of head and neck microvascular free tissue transfer (HN-MFTT). STUDY DESIGN: Retrospective study of consecutive HN-MFTTs performed from January 2015 to July 2020. SETTING: Tertiary academic medical center. METHODS: Thirty-day postoperative antibiotic use and post-HN-MFTT surgical and medical complications were assessed. Univariable analyses and multivariable logistic regression were used to evaluate risk factors associated with restarting antibiotics. RESULTS: overall 482 patients with 501 HN-MFTTs were stratified by duration of prophylaxis: ≤24 hours (n = 136, 27.1%), 25-72 hours (n = 54, 10.8%), and >72 hours (n = 311, 62.1%). Antibiotics were restarted in 199 patients (209 procedures, 42%). The most common indications for antibiotic reinitiation were flap recipient site infection (n = 59, 28%); hospital-acquired pneumonia (n = 44, 21%); and wound dehiscence, fluctuance, or change in quality of drain output (n = 44, 21%). Shorter antibiotic prophylaxis (≤24 hours) (odds ratio [OR], 1.95; 95% CI, 1.2-3.0; P = .003), osteocutaneous flaps (OR, 2.15; 95% CI, 1.3-3.4; P = .001), and prior immunotherapy/chemotherapy (OR, 2.29; 95% CI, 1.2-4.3; P = .01) were associated with reinitiation of antibiotics for surgical infections. Restarting antimicrobials for nosocomial infections was associated with aerodigestive defects (OR, 2.45; 95% CI, 1.1-5.2; P = .019), cardiovascular disease (OR, 3.00; 95% CI, 1.5-5.9; P = .001), and medical comorbidities approximated by American Society of Anesthesiologists class 3 or 4 (OR, 2.83; 95% CI, 1.5-5.4; P = .002). CONCLUSION: Aerodigestive reconstruction, 24-hour postoperative antimicrobial prophylaxis, American Society of Anesthesiologists class 3 and 4, prior chemotherapy/immunotherapy, cardiovascular disease, and osteocutaneous flaps are associated with reinitiation of antibiotics within 30 days of HN-MFTT.
引用
- Plonowska-Hirschfeld KA, Zebolsky AL, Lindeborg MM, et al. Restarting Therapeutic Antibiotics Following Postoperative Prophylaxis in Head and Neck Microvascular Free Tissue Transfer. Otolaryngol Head Neck Surg. 2023. PMID: 35972809. doi:10.1177/01945998221117794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。